Emerald Mutual Fund Advisers Trust’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-17,116
Closed -$594K 264
2019
Q4
$594K Hold
17,116
0.02% 196
2019
Q3
$542K Buy
+17,116
New +$674K 0.02% 191

Other funds holding HCAT

Emerald Mutual Fund Advisers Trust's HCAT Position: Q1 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of Health Catalyst (HCAT) in Q1 2020, closing a stake of 17,116 shares — an estimated $594K sold.

Emerald Mutual Fund Advisers Trust first reported a position in HCAT in Q3 2019 and held it in 2 quarters. The position peaked at $594K in Q4 2019. 108 funds tracked by Wall St. Rank hold HCAT as of Q1 2020.

  • Emerald Mutual Fund Advisers Trust reported no remaining Health Catalyst position as of Q1 2020 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 17,116 Health Catalyst shares in Q1 2020, an estimated $594K.
  • Emerald Mutual Fund Advisers Trust first reported a position in Health Catalyst in Q3 2019 and held it in 2 quarters.
  • Emerald Mutual Fund Advisers Trust's Health Catalyst position peaked at $594K in Q4 2019.
  • 108 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2020, filed 30 Apr 2020.